Blocking PI3K/AKT signaling inhibits bone sclerosis in subchondral bone and attenuates post‐traumatic osteoarthritis

C Lin, Y Shao, C Zeng, C Zhao, H Fang… - Journal of cellular …, 2018 - Wiley Online Library
… ; Lu et al., 2017; Zhang et al., 2016), we hypothesized that the subchondral bone
sclerosis of PTOA may be derived from the PI3K/AKT over-activation in the preosteoblasts/osteoblasts. …

[HTML][HTML] The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review

K Sun, J Luo, J Guo, X Yao, X Jing, F Guo - Osteoarthritis and cartilage, 2020 - Elsevier
… Additionally, blocking PI3K/AKT signaling with LY294002 reduces bone sclerosis in
subchondral bone, and delays post-traumatic osteoarthritis 71 . Apart from well characterized …

PI3K/Akt signaling pathway and bone destruction: problems and mechanisms

D Shi, M Dong, Y Lu, W Niu - Chinese Journal of Tissue Engineering …, 2020 - cjter.com
bone formation. These results reveal that further exploration on the inhibitors of the PI3K/Akt
signaling pathway related to bone … Blocking PI3K/AKT signaling inhibits bone sclerosis in …

Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma

L Yang, S Serada, M Fujimoto, M Terao, Y Kotobuki… - PloS one, 2012 - journals.plos.org
… Although WT mice showed marked cutaneous sclerosis with increased expression of … -mediated
PI3K/Akt signaling either with anti-αv functional blocking antibody or with the PI3K/Akt

PI3K/Akt signaling in osteosarcoma

J Zhang, XH Yu, YG Yan, C Wang, WJ Wang - Clinica chimica acta, 2015 - Elsevier
bone sarcoma that occurs predominantly in children and adolescents, comprising approximately
20% of all boneAkt can phosphorylate tuberous sclerosis complex (Tsc) 2, a tumor …

mTOR inhibition rescues osteopenia in mice with systemic sclerosis

C Chen, K Akiyama, D Wang, X Xu, B Li… - Journal of Experimental …, 2015 - rupress.org
… Loss of function of Fbn1 induced a bone disorder involving elongated bone length and … To
further confirm that the IL4–IL4Rα pathway activates mTOR signaling, we performed a dosage …

Bone marrow mesenchymal stromal cells ameliorate angiogenesis and renal damage via promoting PI3k-Akt signaling pathway activation in vivo

X Jia, J Pan, X Li, N Li, Y Han, X Feng, J Cui - Cytotherapy, 2016 - Elsevier
… We used Western blot to determine protein expression of p-Akt and Akt in renal tissues. …
VEGF-induced angiogenesis is mediated through activating PI3k-Akt signaling pathway. …

Role of PI3K/Akt signaling pathway in cardiac fibrosis

W Qin, L Cao, IY Massey - Molecular and cellular biochemistry, 2021 - Springer
bone marrow-derived fibroblasts recruited into various fibrotic lesions. Mice were engrafted
with bone … directly phosphorylates and thereby inhibits tuberous sclerosis protein 1/2 (TSC1/2…

Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies

KM Keppler‐Noreuil, VER Parker… - American Journal of …, 2016 - Wiley Online Library
… effector of the PI3K/AKT signaling pathway. mTOR exists as two … via AKT-mediated inhibition
of tuberous sclerosis complex 1 … (B) Bony overgrowth with ulnar deviation of his bilateral 2nd …

[HTML][HTML] Triiodothyronine potentiates angiogenesis-related factor expression through PI3K/AKT signaling pathway in human osteoarthritic osteoblasts

L Li, Y Pang, L Zhang, M Li, C Zhu… - Iranian Journal of Basic …, 2020 - ncbi.nlm.nih.gov
… changes of subchondral bone may be the initiation of OA (20). In fact, the abnormally
proliferating osteoblasts in OA are closely related to subchondral bone sclerosis, inflammation, and …